Differential induction of IL-12 p40 and IL-10 mRNA in human langerhans' cells and keratinocytes by in vivo occlusion, vehicle, and all-TRANS retinoic acid

Journal of Cutaneous Medicine and Surgery

Volumn 1, Issue 2, 1996, Pages 74-80

  Chen, Guofen ^a   Kang, Kefei ^a   Kang, Sewon ^b   Rook, Alain H ^c   Kubin, Marek ^d   Voorhees, John J ^b   Cooper, Kevin D ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DRUG VEHICLE; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; OPSITE; RETINOIC ACID;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HYDRATION; IMMUNOMODULATION; KERATINOCYTE; LANGERHANS CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; SKIN; TOPICAL DRUG ADMINISTRATION;

EID: 0030316941     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549600100203     Document Type: Article

References (21)

1. Kang K, Kubin M, Cooper KD, et al. IL-12 synthesis by human Langerhans' cells. J Immunol 1996; 156:1402-1407.
2. Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995; 154:5071-5079.
3. Muller G, Saloga J, Germann T, et al. Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 1994; 94:1799-1805.
4. Trinchieri G, Wysocka M, D'Andrea A, et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 1992; 4:355-368.
5. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-276.
6. D'Andrea A, Rengaraju M, Valiante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176:1387-1398.
7. Kang K, Hammerberg C, Meunier L, et al. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994; 153:5256-5264.
8. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149:92-95.
9. Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol 1993; 11:165-190.
10. D'Andrea A, Aste-Amezaga M, Valiante NM, et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041-1048.
11. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
12. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-1220.
13. Enk AH, Saloga J, Becker D, et al. Induction of hapten-specific tolerance by IL-10 in vivo. J Invest Dermatol 1994; 102:545.
14. Orfanos CE, Ehlert R, Gollnick H. The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 1987; 34:459-503.
15. Meunier L, Bohjanen K, Voorhees JJ, et al. Retinoic acid upregulates human Langerhans' cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. J Invest Dermatol 1994; 103:775-779.
16. Dunlop KJ, Halliday GM, Barnetson RSC. All-trans retinoic acid induces functional maturation of epidermal Langerhans' cells and protects their accessory function from ultraviolet radiation. Exp Dermatol 1994; 3:204-211.
17. Meunier L, Voorhees JJ, Cooper KD. In vivo retinoic acid modulates expression of the Class II major histocompatibility complex and the function of antigen-presenting macrophages and keratinocytes in ultraviolet-exposed human skin. J Invest Dermatol 1996; 106:1042-1046.
18. Meunier L, Gonzalez-Ramos A, Cooper KD. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans' cells. J Immunol 1993; 151:4067-4080.
19. Rook AH, Kang K, Kubin M, et al. Interleukin 12 mRNA and protein production by epidermal Langerhans' cells. Clin Res 1994; 42:231A.
20. Mikulowska A. Reactive changes in the Langerhans' cells of human skin caused by occlusion with water and sodium lauryl sulphate. Acta Derm Venereol (Stockh) 1990; 70:468-473.
21. Ashworth J, Booker J, Breathnach SM. Effects of topical corticosteroid therapy on Langerhans' cell antigen presenting function in human skin. Br J Dermatol 1988; 118:457-469.